2017Bladder CancerOpen access

Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer

Richard S. Matulewicz, John Oliver DeLancey, Emily S. Pavey, Edward Matthew Schaeffer, Oana Popescu, Joshua J. Meeks

Open full text 36 citations

Abstract

Introduction: There is a lack of evidence supporting the routine use of laboratory tests to detect bladder cancer.Identifying a cost-effective and widely available diagnostic aid may improve bladder cancer outcomes.We sought to evaluate the utility of dipstick urinalysis to detect microhematuria and diagnose bladder cancer in a large, diverse, contemporary cohort.Methods: All non-pregnant women and men 35 and older with a new diagnosis of microhematuria (≥3 RBC/hpf) were identified via a multi-center electronic medical record data warehouse query.Negative controls with no history of hematuria were randomly chosen and included to complete our cohort.Comparison between dipstick urinalysis and microscopic urinalysis on self-matched patients for the detection of microhematuria and diagnosis of bladder cancer was performed via Spearman's rank correlation coefficient, sensitivity/specificity testing, and ROC curve analysis.Results: A total of 46,842 patients were included.Spearman's rank order correlation (rho = 0.66) between degree of microhematuria on dipstick urinalysis and microscopic urinalysis indicated a strong positive relationship.The ROC curve for dipstick urinalysis to identify microhematuria had an AUC of 0.80 (95% CI 0.79-0.81).No difference (p = 0.83) in diagnostic accuracy between dipstick urinalysis (AUC 0.74, 95% CI 0.70-0.78)and microscopic urinalysis (AUC 0.73, 95% CI 0.69-0.78)as a test for bladder cancer was found.Conclusion: Dipstick urinalysis provides a highly specific test for microhematuria and similar accuracy to microscopic urinalysis when used as a diagnostic tool to detect bladder cancer.

Open-access reader

About this research paper

What this paper is about

Introduction: There is a lack of evidence supporting the routine use of laboratory tests to detect bladder cancer.Identifying a cost-effective and widely available diagnostic aid may improve bladder cancer outcomes.We sought to evaluate the utility of dipstick urinalysis to detect microhematuria and diagnose bladder cancer in a large, diverse, contemporary cohort.Methods: All non-pregnant women and men 35 and older with a new diagnosis of microhematuria (≥3 RBC/hpf) were identified via a multi-center electronic medical record data warehouse query.Negative controls with no history of hematuria were randomly chosen and included to complete our cohort.Comparison between dipstick urinalysis and microscopic urinalysis on self-matched patients for the detection of microhematuria and diagnosis of bladder cancer was performed via Spearman's rank correlation coefficient, sensitivity/specificity testing, and ROC curve analysis.Results: A total of 46,842 patients were included.Spearman's rank order correlation (rho = 0.66) between degree of microhematuria on dipstick urinalysis and microscopic urinalysis indicated a strong positive relationship.The ROC curve for dipstick urinalysis to identify microhematuria had an AUC of 0.80 (95% CI 0.79-0.81).No difference (p = 0.83) in diagnostic accuracy between dipstick urinalysis (AUC 0.74, 95% CI 0.70-0.78)and microscopic urinalysis (AUC 0.73, 95% CI 0.69-0.78)as a test for bladder cancer was found.Conclusion: Dipstick urinalysis provides a highly specific test for microhematuria and similar accuracy to microscopic urinalysis when used as a diagnostic tool to detect bladder cancer.

Why it matters

OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Introduction: There is a lack of evidence supporting the routine use of laboratory tests to detect bladder cancer.Identifying a cost-effective and widely available diagnostic aid may improve bladder cancer outcomes.We sought to evaluate the utility of dipstick urinalysis to detect microhematuria and diagnose bladder cancer in a large, diverse, contemporary cohort.Methods: All non-pregnant women and men 35 and older with a new diagnosis of microhematuria (≥3 RBC/hpf) were identified via a multi-center electronic medical record data warehouse query.Negative controls with no history of hematuria were randomly chosen and included to complete our cohort.Comparison between dipstick urinalysis and microscopic urinalysis on self-matched patients for the detection of microhematuria and diagnosis of bladder cancer was performed via Spearman's rank correlation coefficient, sensitivity/specificity testing, and ROC curve analysis.Results: A total of 46,842 patients were included.Spearman's rank order correlation (rho = 0.66) between degree of microhematuria on dipstick urinalysis and microscopic urinalysis indicated a strong positive relationship.The ROC curve for dipstick urinalysis to identify microhematuria had an AUC of 0.80 (95% CI 0.79-0.81).No difference (p = 0.83) in diagnostic accuracy between dipstick urinalysis (AUC 0.74, 95% CI 0.70-0.78)and microscopic urinalysis (AUC 0.73, 95% CI 0.69-0.78)as a test for bladder cancer was found.Conclusion: Dipstick urinalysis provides a highly specific test for microhematuria and similar accuracy to microscopic urinalysis when used as a diagnostic tool to detect bladder cancer.

Key concepts: Urinalysis, Microhematuria, Medicine, Dipstick, Bladder cancer, Urology, Receiver operating characteristic, Gold standard (test)

Related papers

Back to paper searchBrowse research topicsOriginal source
Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer — Research Paper | ScholarLens